MARGARET FREGOSO: Open Payments
NPI 1972785442 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 34 payments from 13 companies in 2025. Trend: 2023 $311 · 2024 $981 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 9 | $457 |
| Actelion Pharmaceuticals US, Inc. | 3 | $179 |
| Melinta Therapeutics, LLC | 3 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $137 |
| GlaxoSmithKline, LLC. | 1 | $124 |
| Novo Nordisk Inc | 3 | $77 |
| Abbott Laboratories | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $21 |
Products named: Tyvaso, UPTRAVI, REMODULIN, Rezzayo, NUCALA, Orenitram, OFEV, Wegovy.
Industry payments across VA — which companies pay providers there.
